Press Releases ATON

Equities

ALTAO

FR0004153930

Market Closed - Euronext Paris Other stock markets 09:05:10 03/07/2024 pm IST			5-day change	1st Jan Change
0.0082 ^EUR	+1.23%		-5.75%	-63.06%

25/06	Glassbox Launches Global Partner Network to Drive Enterprise Digital Transformation with AI-Powered CX Solutions	CI
04/06	ITALY GROWTH WINNERS & LOSERS: Bullish plants; Aton Green at the back of the pack.	AN

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ATON : Résultats annuels 2023 – Report de la publication	01/05	PU
ATON : Échelonnement du remboursement de l'emprunt obligataire convertible de 1,5 M€ auprès de Vatel Capital	08/03	PU
ATON : Stemcis étend ses horizons à l’international avec l’ouverture d’une filiale aux États-Unis	26/23/26	PU
Bone Therapeutics : reacts to the press release issued by Hybrigenics	07/21/07	AQ
Hybrigenics : rsquo; compound inhibits Ubiqitin-Specific Protease 10 (USP10) and shows activity in preclinical models of Acute Myeloid Leukemia (AML)	10/17/10	PU
Hybrigenics : Télécharger le document associé Meet Hybrigenics Pharma at SOHO 2017	11/17/11	PU
Hybrigenics : gets European patent protection for inhibitors of Ubiquitin-Specific Protease 8 (USP8)	07/17/07	PU
Hybrigenics : full year 2016 results	29/17/29	PU
Hybrigenics : Strategic refocusing on biopharmaceutical R&D	14/17/14	PU
Hybrigenics : Encouraging preliminary results of the Phase II clinical study of inecalcitol in Chronic Myeloid Leukemia	09/17/09	PU
Hybrigenics' : patent estate of inhibitors of ubiquitin specific proteases continues to expand	27/17/27	PU
Hybrigenics : rsquo; inecalcitol strengthens key patent protection in the United States until 2031	05/16/05	PU
Hybrigenics : receives green light for a double-blind placebo-controlled Phase II clinical study of inecalcitol in Acute Myeloid Leukemia (AML)	07/16/07	PU
Hybrigenics : 2014 first-half results and highlights	29/14/29	PU
Hybrigenics : successfully raised € 4.6 million	23/14/23	PU
Hybrigenics : invests in its genomic capabilities	02/14/02	PU
Hybrigenics' : patent estate of inhibitors of ubiquitin-specific proteases is expanding	05/14/05	PU
Hybrigenics : revenus et trésorerie au premier semestre 2014	11/14/11	PU
HYBRIGENICS : Hybrigenics' General Meeting highlights - Focus on inecalcitol recent update and achievements	06/13/06	PU
HYBRIGENICS : Update on the clinical study of inecalcitol in chronic lymphocytic leukemia	08/13/08	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ATON

Equities

ALTAO

FR0004153930

Press Releases

Filters